CRISPR Therapeutics AG Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 29 Posts
1 2
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Article By: Rod Raynovich Wednesday, June 22, 2022 5:36 AM EDT
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
In this article: LLY, UNH, XLV, CRSP Also: CCXI, EVH, MRTX, MDGL, VCYT
Read
Crispr: A Fallen Angel In Gene Editing
Article By: MoneyShow.com Friday, October 15, 2021 11:31 PM EDT
As with most promising biotech companies, investors bid their prices up for CRSP based on its potential for early profits. When the payoff didn't occur on schedule, investors bailed out. Once it becomes profitable, investors will come flocking back.
In this article: CRSP Also: NVAX, VRTX, RHHBY, AMGN, BIIB, GILD
Read
A Comprehensive Guide To Genomic ETFs
Article By: Zacks Investment Research Sunday, July 11, 2021 1:59 PM EDT
Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon make genomics the next big thing in the space.
In this article: GNOM, PBE, ARKG, IDNA, NTLA, CRSP Also: BEAM, EDIT
Read
Mid-Cap Biotech Picks: Seasonal Rally Underway
Article By: Rod Raynovich Saturday, July 3, 2021 6:54 PM EDT
Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.
In this article: CYRX, CRSP, VCYT Also: ARKG, XBI
Read
Inside Actively Managed Equity ETFs - A Topic Of Increasing Importance
Article By: Herbert Blank Thursday, February 4, 2021 10:48 AM EDT
Today’s analysis covers sevenal actively managed ETFs. A handful have had tremendous success in performance and asset capture. Most, thus far, have not. Seven ETFs are compared to SPY as a benchmark with distinctive results.
In this article: HUSV, SPY, VTI, ARKW, ARKK, NVTA, FTHI, CRSP, CWS, AIEQ, TTAC
Read
Humble Beginnings Of Game-Changing Companies
Article By: Tim Knight Thursday, January 7, 2021 6:11 PM EDT
While relatively young, these stocks have the same kind of impressive stock chart TSLA did. TSLA didn’t look like much eight years ago, but to a discerning eye, the chart had the right stuff.
In this article: NIO, TSLA, MRNA, CRSP, UBER, SWAV, CRWD, SNDL
Read
5 New Superstars
Article By: Tim Knight Sunday, November 29, 2020 9:05 PM EDT
I went through my watch list of relatively young stocks, and there are some which stand out as particularly bullish patterns.
In this article: MRNA, CRSP, CHWY, NET, BNTX
Read
Biotech Stock Playbook In A Choppy Momentum Market
Article By: Rod Raynovich Tuesday, September 29, 2020 4:57 AM EDT
Biotech stocks peaked in mid-July but we have assumed a fourth quarter rally driven by clinical news in oncology and important scientific breakthroughs in diagnostic testing for coronavirus and COVID vaccine data.
In this article: ABT, AZN, BMY, GSK, JNJ, MRK, RHHBY, GNMK, NVAX, OSUR, QDEL, HOLX, PACB, ABBV, AXDX, EDIT, CRSP
Read
Technical Analysis For 7 US Stocks: CERS, CGEN, CLLS, CRM, CRSP, CRWD, CSTL
Video By: Peter Mathers Saturday, September 5, 2020 11:07 AM EDT
Price Technical Analysis Elliott Wave and Trading Levels for Cerus, Compugen, Cellectis, Salesforce, Crisper, Crowdstrike and Castle Biosciences.
In this video: CRM, CERS, CGEN, CLLS, CRSP, CRWD, CSTL
Watch
Technical Analysis For Alibaba, Crispr Therapeutics, Nanostring, ExOne, Materialise And Proto Labs
Video By: Peter Mathers Monday, August 24, 2020 5:18 AM EDT
Technical analysis for the following stocks: BABA, CRSP, NSTG, XONE, MTLS, PRLB​​​​​​​.
In this video: PRLB, BABA, XONE, NSTG, MTLS, CRSP
Watch
Alibaba, Crispr Therapeutics, Nanostring, ExOne, Materialise And Proto Labs - Technical Analysis
Video By: Peter Mathers Friday, August 14, 2020 4:21 AM EDT
A review of Alibaba, Crispr Therapeutics, Nanostring, ExOne, Materialise and Proto Labs.
In this video: BABA, XONE, NSTG, MTLS, CRSP, PRLB
Watch
Alibaba - Nanostring - Crispr - Exone - Proto Labs - Materialise Analysis
Video By: Peter Mathers Monday, August 3, 2020 5:21 AM EDT
TradingLounge US Stock Market Update: Alibaba, Crispr Therapeutics, Nanostring, ExOne, Materialise, Proto Labs, Technical Analysis Elliott Wave & Trading Levels
In this video: PRLB, BABA, XONE, NSTG, MTLS, CRSP
Watch
Technical Analysis: Alibaba, Crispr, NanoString, ExOne, Materialise And Proto Labs Analysis
Video By: Peter Mathers Thursday, July 23, 2020 3:36 AM EDT
A review of Alibaba, Crispr Therapeutics, Nanostring, ExOne, Materialise and Proto Labs.
In this video: PRLB, BABA, XONE, NSTG, MTLS, CRSP
Watch
Alibaba, Crispr Therapeutics, NanoString - Technical Analysis
Video By: Peter Mathers Thursday, July 9, 2020 3:44 AM EDT
A review of Alibaba, Crispr Therapeutics and NanoString.
In this video: CRSP, BABA, NSTG
Watch
How Subtle Chart Patterns Can Lead To Explosive Rallies
Article By: Deron Wagner Tuesday, December 24, 2019 7:10 AM EDT
Stock traders who focus on trading only the most obvious chart patterns are missing out on huge gains that more subtle patterns can provide.
In this article: CRSP
Read
Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum
Article By: Rod Raynovich Saturday, November 30, 2019 11:38 PM EDT
IBB is up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %. The big winners for the month include NTLA up 47.24%.
In this article: IBB, QQQ, XBI, SRPT, NTLA, CRSP
Read
1 to 16 of 29 Posts
1 2